Immunovia
Diagnostics company developing a blood test for early pancreatic cancer detection.
IMMNOV | ST
Overview
Corporate Details
- ISIN(s):
- SE0006091997 (+2 more)
- LEI:
- 549300KHWL6KK1XGUO81
- Country:
- Sweden
- Address:
- Scheelevägen 8, 223 63 LUND
- Website:
- https://immunovia.com/
- Industry:
- Other human health activities
Description
Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2019-12-19 11:20 |
Immunovia Announces Achieving a Major Milestone with the Successful Completion …
|
English | PDF • 244.7 KB | ||
| 2019-12-09 13:52 |
Immunovia stärker ledningsteamet inför sin kommersiella lansering av IMMray® Pa…
|
Swedish | PDF • 176.3 KB | ||
| 2019-12-09 13:52 |
Immunovia Strengthens Management Team Ahead of its Commercial Launch of IMMray™…
|
English | PDF • 182.8 KB | ||
| 2019-11-29 14:00 |
Immunovia continues with next stage of the Lung Cancer Project together with Gl…
|
English | PDF • 175.1 KB | ||
| 2019-11-29 14:00 |
Immunovia fortsätter med nästa fas i lungcancerprojektet tillsammans med global…
|
Swedish | PDF • 168.3 KB | ||
| 2019-11-08 19:25 |
Correction: Immunovia Interim Report, January-September 2019
|
English | PDF • 2.0 MB | ||
| 2019-11-08 18:53 |
Korrigerad version: Immunovia delårsrapport januari-september 2019
|
Swedish | PDF • 2.0 MB | ||
| 2019-11-08 08:00 | Swedish | PDF • 1.3 MB | |||
| 2019-11-08 08:00 | English | PDF • 1.3 MB | |||
| 2019-11-04 16:30 |
Immunovia AB (Publ) nomination committee appointed for AGM 2020
|
English | PDF • 296.7 KB | ||
| 2019-11-04 16:30 |
Valberedning utsedd inför årsstämma 2020 i Immunovia AB (Publ)
|
Swedish | PDF • 294.2 KB | ||
| 2019-10-22 14:15 |
Uppdatering från Immunovia om dess pipelineprojekt inom reumatoid artrit samt m…
|
Swedish | PDF • 351.0 KB | ||
| 2019-10-22 14:15 |
Immunovia Provides an Update on its Rheumatoid Arthritis Pipeline Project and A…
|
English | PDF • 390.9 KB | ||
| 2019-10-02 08:30 |
Immunovia Provides an Update on its Lung Cancer Pipeline Projects
|
English | PDF • 313.5 KB | ||
| 2019-10-02 08:30 |
Immunovia lämnar uppdatering om sina pågående lungcancerprojekt
|
Swedish | PDF • 282.0 KB |
Automate Your Workflow. Get a real-time feed of all Immunovia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immunovia
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immunovia via our API.
Peer Companies
